MAL18116088ACZPrescription (MAL-A)

Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets

Generic Molecule: Emtricitabine

ACTIVE & APPROVEDValid till: 16 Nov 2028
NPRA Official Regulatory Summary

Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets is a KKM-approved Prescription Medicine registered under MAL number MAL18116088ACZ by Gilead Sciences Malaysia Sdn. Bhd.. Its active ingredient is EMTRICITABINE 200.00 mg, Tenofovir alafenamide fumarate 28.0 mg, manufactured by PATHEON INC.

Holder (PRH)
Gilead Sciences Malaysia Sdn. Bhd.
Manufacturer
PATHEON INC
First Registered
16 Nov 2023
Validity
16 Nov 2028

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
EMTRICITABINE200.00 mgFind Brands
Tenofovir alafenamide fumarate28.0 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL18116088ACZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets approved by KKM / NPRA?

Yes. Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL18116088ACZ with current status PRODUCT APPROVED. Registration was filed by Gilead Sciences Malaysia Sdn. Bhd..

What are the active ingredients of Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets?

The declared active therapeutic components are: EMTRICITABINE 200.00 mg, Tenofovir alafenamide fumarate 28.0 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 8 registered brand formulations containing identical active ingredients (Emtricitabine). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Descovy (emtricitabine 200 mg/ tenofovir alafenamide 25 mg) film-coated tablets (MAL18116088ACZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.